<DOC>
	<DOCNO>NCT02771782</DOCNO>
	<brief_summary>This study three purpose : To investigate whether immune response pertussis increase TDaP-IPV give together BCG vaccine , compare give alone . To investigate whether BCG vaccination modulates immune response non vaccine target antigen ( i.e. , antigens/pathogens use vaccine ) . To investigate whether TDaP-IPV vaccination modulates immune response non vaccine target antigen .</brief_summary>
	<brief_title>Influence BCG TDaP-IPV Vaccination</brief_title>
	<detailed_description>Rationale : The Bacillus Calmette-Guerin ( BCG ) vaccine protect Mycobacterium tuberculosis , also show reduce morbidity mortality cause non-related infection . This effect likely due non-specific immunomodulatory effect , least part innate immune system . Additionally , BCG show improve immunogenicity vaccination . In contrast , whilst diphtheria-tetanus-pertussis ( DTP ) combination vaccine protect infection Bordetella pertussis , Clostridium tetani Corynebacterium diphtheria , also associate increased mortality due unrelated infection , particularly girls high-mortality country . Although widespread DTP vaccination initially reduce pertussis mortality , disease persist recently resurge number country highly vaccinated population , include Netherlands . This partially attributed switch whole-cell vaccine ( still use low-income country ) define acellular pertussis vaccine , protects limited period ( 5-8 year ) . Strategies improve efficacy pertussis vaccination therefore urgently require . As BCG vaccine already use improve immunogenicity vaccine , investigator hypothesize BCG vaccination time DTP vaccination increase immunogenicity DTP vaccine term antibody T-cell response pertussis . Moreover , investigator aim assess effect DTP vaccination know long-term beneficial non-specific effect BCG non-mycobacterial infection . Objective : To examine effect BCG adjuvant DTP vaccination , investigate non-specific training effect BCG DTP , alone combination , innate immune system . Study population : Healthy adult volunteer . Main study parameter : Comparison pertussis-specific antibody T-cell response , well gene transcription BCG , TDaP-IPV BCG+TDaP-IPV vaccinate group . Comparison cytokine response unrelated antigen and/or pathogen BCG , TDaP-IPV BCG+TDaP-IPV vaccination . Nature extent burden risk associate participation , benefit group relatedness : There direct benefit study participant result potentially lead novel strategy optimize vaccination . The risk participant negligible , expect risk minor side-effects vaccination local hematoma form site venepuncture . This minimized performance procedure experience personnel .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>BCG Vaccine</mesh_term>
	<criteria>healthy female systemic medication use oral contraceptive drug history disease result immunodeficiency previous vaccination BCG pregnancy allergy neomycin polymyxin know previous allergic reaction vaccination diphteria , tetanus , pertussis polio vaccines One follow phenomenon previous vaccination pertussis contain antigen : Fever &gt; 40 Â°C within 48 hour vaccination , hypotonoushyporesponsiveness episode within 48 hour vaccination , convulsion without fever within 3 day vaccination</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>BCG</keyword>
	<keyword>TDaP-IPV</keyword>
	<keyword>DPT Vaccine</keyword>
</DOC>